ZMYM3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.7528201112782E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.11939959710628E-10 |
Normal-vs-Stage2 |
4.352900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
8.198600E-03 |
Stage1-vs-Stage2 |
1.455750E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.177600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.205200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.8782310696206E-12 |
Normal-vs-AfricanAmerican |
3.643400E-01 |
Normal-vs-Asian |
5.398000E-02 |
Caucasian-vs-AfricanAmerican |
7.779600E-01 |
Caucasian-vs-Asian |
1.638370E-01 |
AfricanAmerican-vs-Asian |
4.314600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.99839999998264E-07 |
Normal-vs-Female |
3.72230000156293E-08 |
Male-vs-Female |
4.692400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.221200E-03 |
Normal-vs-Extreme_Weight |
1.65789999950761E-07 |
Normal-vs-Obese |
1.275410E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.291200E-01 |
Normal_Weight-vs-Obese |
8.073600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.498200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.816390E-01 |
Normal-vs-Age(41-60Yrs) |
1.596140E-04 |
Normal-vs-Age(61-80Yrs) |
9.89620052571638E-10 |
Normal-vs-Age(81-100Yrs) |
4.678600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.885600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.036400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.324400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.377200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.949200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.107900E-02 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.893600E-01 |
Normal-vs-Grade 3 |
8.388000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.355800E-01 |
Grade 2-vs-Grade 4 |
9.893600E-01 |
Grade 3-vs-Grade 4 |
8.388000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.28910004892901E-09 |
Normal-vs-N1 |
4.382100E-03 |
N0-vs-N1 |
1.507410E-01 |
|
|